These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36748921)

  • 1. Less Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome Combined With Noninvasive Ventilation in Anhui Province, China: A Retrospective Cohort Study.
    Zhang X; Pan J; Zhu L; Ye Y; Fan Z; Chen X; Wang H; Wei G; Zhang L
    Clin Pediatr (Phila); 2023 Oct; 62(9):1109-1117. PubMed ID: 36748921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis.
    Mansouri M; Servatyari K; Rahmani K; Sheikhahmadi S; Hemmatpour S; Eskandarifar A; Rahimzadeh M
    J Neonatal Perinatal Med; 2024; 17(2):233-239. PubMed ID: 38759030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses.
    Silveira RC; Panceri C; Munõz NP; Carvalho MB; Fraga AC; Procianoy RS
    J Pediatr (Rio J); 2024; 100(1):8-24. PubMed ID: 37353207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study evaluating the combination of LISA and SNIPPV for the treatment of respiratory distress syndrome in preterm infants.
    Permall DL; Zhang Y; Li H; Guan Y; Chen X
    Sci Rep; 2024 Jan; 14(1):1429. PubMed ID: 38228632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
    Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
    [No Abstract]   [Full Text] [Related]  

  • 10. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
    Halim A; Shirazi H; Riaz S; Gul SS; Ali W
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less Invasive Surfactant Administration (LISA) Versus INSURE Method in Preterm Infants: a Retrospective Study.
    Dini G; Santini MG; Celi F
    Med Arch; 2024; 78(2):112-116. PubMed ID: 38566872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
    Mishra A; Joshi A; Londhe A; Deshmukh L
    Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
    Gupta BK; Saha AK; Mukherjee S; Saha B
    Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
    Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
    Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
    Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
    Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less invasive surfactant administration (LISA): chances and limitations.
    Herting E; Härtel C; Göpel W
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F655-F659. PubMed ID: 31296694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of less invasive surfactant administration in the treatment of neonatal respiratory distress syndrome: a Meta analysis].
    Huo MY; Mei H; Zhang YH; Liu CZ; Hu YN; Song D
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):721-727. PubMed ID: 32669168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Comparison of LISA and INSURE techniques in term of neonatal morbidities and mortality among premature infants.
    Silahli M; Tekin M
    Acta Biomed; 2020 Nov; 91(4):e2020189. PubMed ID: 33525282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
    Liu MM; Ji L; Dong MY; Zhu XF; Wang HJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan; 24(1):78-84. PubMed ID: 35177180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.